Asbestos and Lung Disease: The Damage That Goes Far Beyond Cancer
Most people associate asbestos with mesothelioma. What rarely gets discussed is the far broader spectrum of lung damage — irreversible scarring, chronic breathlessness, and progressive disease that never becomes malignant but strips people of their quality of life for decades.
The scale of this is not trivial. US hospital data recorded over 20,000 discharges attributed to asbestosis in a single year, alongside approximately 2,000 deaths. That figure sits entirely separate from the cancer burden — it represents only the non-malignant cases serious enough to require hospitalisation.
If you own, manage, or work in a building that might contain asbestos-containing materials (ACMs), understanding the full range of health consequences — not just cancer — changes how seriously you approach your legal obligations. It also makes clear why proper surveying and ongoing management are fundamental duties, not administrative box-ticking.
The Non-Cancerous Lung Diseases Linked to Asbestos Exposure
Asbestos-related illness spans a wide spectrum. While mesothelioma and lung cancer dominate public awareness, several serious non-malignant conditions result from asbestos exposure — and they affect significantly more people than the cancers do.
Asbestosis
Asbestosis is a progressive fibrotic lung disease caused by prolonged inhalation of asbestos fibres. The condition was formally named in 1927, though cases had been documented in industrial workers well before that.
Fibres lodge deep in lung tissue and trigger a scarring response that progressively stiffens the lungs, making breathing increasingly difficult. The disease is irreversible — once the scarring establishes itself, it cannot be undone, and it typically continues to progress even after exposure has ceased.
Symptoms include breathlessness, a persistent dry cough, and in advanced cases, clubbing of the fingers. Patients with asbestosis also carry an elevated risk of developing lung cancer.
The occupational data illustrates how widespread this condition can be. A study tracking over 18,000 sheet metal workers found that 9.6% had developed asbestosis and 21% had some form of pleural disease — a direct reflection of decades of heavy exposure in industries where asbestos was used routinely.
Pleural Plaques
Pleural plaques are areas of thickened, calcified tissue that develop on the pleura — the lining of the lungs. They are the most common marker of past asbestos exposure and are frequently identified incidentally during chest X-rays or CT scans carried out for unrelated reasons.
In occupational groups with significant asbestos exposure, incidence rates of pleural plaques range from 20% to 60%. In the general population without occupational exposure, rates fall between 2% and 6%. The difference reflects cumulative fibre burden accumulated over working lifetimes.
Pleural plaques themselves do not cause cancer. An international expert meeting concluded that parietal pleural plaques alone do not cause lung cancer or mesothelioma. However, their presence is a clear indicator that significant asbestos exposure has occurred — and that exposure independently carries elevated cancer risk.
Diffuse Pleural Thickening
Unlike discrete plaques, diffuse pleural thickening involves widespread scarring across the pleural membrane. This can significantly restrict lung expansion and cause breathlessness that worsens progressively over time.
It tends to follow more intense or prolonged exposure and can be seriously debilitating even without any malignant development.
Benign Asbestos Pleural Effusion
Benign asbestos pleural effusion involves fluid accumulating in the pleural space. It can develop relatively soon after initial exposure — sometimes within a decade — and may cause chest pain and breathlessness.
While benign in itself, it warrants careful monitoring because it can precede more serious conditions including diffuse pleural thickening.
How Asbestos Fibres Actually Damage Lung Tissue
Understanding the biological mechanism helps explain why asbestos is so destructive — and why different fibre types carry different levels of risk.
When asbestos fibres are inhaled, the body attempts to clear them. Amphibole fibres — including crocidolite (blue asbestos) and amosite (brown asbestos) — are needle-like and biopersistent. They resist the body’s natural clearance mechanisms and can remain lodged in lung tissue for decades.
Chrysotile (white asbestos) breaks down more readily, though it is not safe by any measure and remains a significant health hazard.
Iron associated with asbestos fibres generates reactive oxygen species — unstable molecules that attack DNA and damage the cells lining the alveoli, the tiny air sacs responsible for gas exchange. This oxidative stress triggers inflammation and activates cell death pathways.
Inflammatory mediators sustain and amplify this damage over time, leading to progressive fibrosis — the lung tissue becomes scarred and loses its elasticity. Once established, this process is self-perpetuating even after all exposure has ceased. That is what makes asbestos-related lung disease so insidious: the damage continues long after the source is removed.
What the 20,000 Discharges Figure Actually Tells Us
The figure of over 20,000 discharges for asbestosis recorded in US hospital data in a single year — alongside approximately 2,000 deaths — represents a specific, measurable slice of the non-malignant asbestos disease burden. It excludes the cancer cases. It excludes the many patients managing their condition without hospitalisation.
The true scale of asbestos-related non-malignant disease is considerably larger than any single hospitalisation statistic can capture.
This matters in a UK context because many of the buildings responsible for this legacy of disease are still standing. The UK used asbestos extensively in construction from the 1950s through to the late 1990s. Any building constructed or refurbished before the year 2000 may contain ACMs, and the duty to manage them falls squarely on building owners and duty holders.
The diseases described above — asbestosis, pleural thickening, pleural plaques — are the consequences of uncontrolled exposure in workplaces and buildings where asbestos was disturbed without adequate precautions. Preventing further cases requires proper identification, management, and control of ACMs in the buildings that still contain them.
Diagnosis and Clinical Management of Asbestos-Related Lung Disease
Diagnosing asbestos-related lung disease requires a combination of detailed occupational history and imaging. Clinicians rely on chest X-rays and high-resolution CT scanning to identify pleural changes and parenchymal fibrosis. Lung biopsy may be used in less clear-cut cases where imaging alone is inconclusive.
There is currently no treatment that reverses asbestosis or pleural fibrosis. Clinical management focuses on slowing progression, managing symptoms, and monitoring for malignant change. This includes pulmonary rehabilitation, oxygen therapy where appropriate, and regular surveillance imaging to detect any transition towards malignancy at the earliest possible stage.
Regulatory exposure limits exist to protect workers from ongoing exposure. Under the Control of Asbestos Regulations, control limits for airborne asbestos fibre concentrations apply in workplaces. In occupied buildings under normal conditions, airborne fibre levels typically remain low — but renovation, demolition, or unplanned disturbance of ACMs can cause levels to spike dramatically.
This is precisely why surveying and management before any building work begins are not optional.
What This Means for Building Owners and Duty Holders
The health data is unambiguous. The 20,000 discharges figure and the occupational disease rates documented among sheet metal workers and similar trades represent the legacy of decades of uncontrolled asbestos use. Many of those buildings are still occupied. Many still contain ACMs.
Under the Control of Asbestos Regulations, duty holders — owners and managers of non-domestic premises — have a legal obligation to identify, assess, and manage asbestos. This obligation is directly connected to preventing the kinds of lung disease described above from affecting anyone who works in or visits your building.
The HSE’s HSG264 guidance sets out the practical framework for meeting this duty. The duty to manage requires you to:
- Identify whether ACMs are present through a suitable survey
- Assess the condition and risk of any ACMs found
- Produce and maintain an asbestos register
- Implement a management plan and keep it under regular review
- Inform anyone who might disturb ACMs of their location and condition
Failure to comply is a criminal offence and can result in significant fines. More importantly, it puts real people at genuine risk of the conditions described in this article — conditions that are irreversible once established.
Choosing the Right Asbestos Survey for Your Building
Not all surveys serve the same purpose. The type of survey you need depends on what you are doing with the building and what stage of the management process you are at.
Management Survey
A management survey is the standard survey for buildings in normal occupation. It identifies the location, extent, and condition of any ACMs that could be disturbed during routine maintenance or occupancy, and forms the basis of your asbestos register and management plan.
If you do not have an up-to-date register, this is where you start.
Refurbishment Survey
Before any renovation work, a refurbishment survey is legally required. This is a more intrusive investigation that locates all ACMs in areas to be disturbed, ensuring contractors are not unknowingly cutting into asbestos-containing materials and releasing fibres into the air.
Skipping this step is one of the most common causes of accidental asbestos exposure during building works.
Demolition Survey
Where a building or part of a building is being demolished, a demolition survey is required. This is the most intrusive type of survey and must cover the entire structure, ensuring all ACMs are identified and removed before demolition proceeds. HSG264 is explicit on this requirement.
Re-inspection Survey
Where ACMs are being managed in situ rather than removed, a periodic re-inspection survey checks that their condition has not deteriorated. HSG264 recommends regular re-inspection to ensure the management plan remains effective and that any change in condition is identified promptly before fibres are released.
Fire Risk Assessment
Asbestos management does not operate in isolation from other safety obligations. A fire risk assessment is a separate legal requirement for non-domestic premises and complements your asbestos management obligations — particularly where fire could damage ACMs and release fibres into the air, creating a compound hazard.
Practical Steps You Can Take Right Now
If you are unsure whether your building contains asbestos, do not guess and do not wait. Early action is far simpler and less costly than dealing with the consequences of unmanaged ACMs — or the human cost of preventable disease.
- Commission a management survey if you do not already have an up-to-date asbestos register. This is your legal starting point.
- Review your existing register — if it is more than a few years old, or conditions in the building have changed, it may need updating.
- Book a re-inspection if ACMs are being managed in situ and have not been checked recently.
- Order a testing kit if you want to check a specific material before a surveyor visits — samples are sent for laboratory analysis and results returned promptly.
- Brief your contractors — anyone working in your building must be made aware of the asbestos register before starting any work that could disturb materials.
Supernova Asbestos Surveys operates across the UK. If you are based in the capital, our asbestos survey London service covers all London boroughs. We also provide a full asbestos survey Manchester service across Greater Manchester, and our asbestos survey Birmingham team covers the West Midlands and surrounding areas.
With over 50,000 surveys completed nationwide, our UKAS-accredited surveyors deliver accurate, legally compliant reports that give you the information you need to protect your building, your occupants, and yourself.
Call us on 020 4586 0680 or visit asbestos-surveys.org.uk to book your survey or request a quote.
Frequently Asked Questions
What is the difference between asbestosis and mesothelioma?
Asbestosis is a non-cancerous fibrotic lung disease caused by prolonged inhalation of asbestos fibres, resulting in progressive scarring of lung tissue. Mesothelioma is a malignant cancer affecting the lining of the lungs or abdomen. Both are caused by asbestos exposure, but they are distinct conditions with different prognoses and clinical management pathways. Asbestosis affects significantly more people than mesothelioma, as reflected in figures such as the over 20,000 hospital discharges recorded for asbestosis in US data — a count that sits entirely separate from cancer cases.
Can you get lung disease from a single exposure to asbestos?
Non-malignant conditions such as asbestosis typically require prolonged or repeated exposure to develop. However, there is no established safe threshold for asbestos exposure, and even relatively limited exposure can elevate the risk of malignant disease. Any suspected disturbance of ACMs should be treated seriously, and professional assessment should be sought promptly.
Are pleural plaques dangerous?
Pleural plaques themselves are not cancerous and do not directly cause lung cancer or mesothelioma. However, their presence confirms that significant asbestos exposure has occurred, and that exposure independently increases the risk of developing asbestos-related cancer. Anyone with a confirmed diagnosis of pleural plaques should be under appropriate medical surveillance.
Who is legally responsible for managing asbestos in a building?
Under the Control of Asbestos Regulations, the duty holder is responsible for managing asbestos in non-domestic premises. This is typically the building owner, landlord, or the person or organisation with control over the building through a lease or management agreement. The duty requires them to identify ACMs, assess their condition, maintain an asbestos register, and implement a management plan. Failure to comply is a criminal offence.
How often should an asbestos re-inspection be carried out?
HSG264 guidance recommends that ACMs being managed in situ are re-inspected at regular intervals — typically annually, though higher-risk materials or those in areas subject to frequent disturbance may warrant more frequent checks. The purpose is to identify any deterioration in condition before fibres are released. Your asbestos management plan should specify the re-inspection schedule appropriate to your building and the materials present.